The Bowery Funds group shares their thoughts on the emergence of usage centered pricing in technologies and why it could turn out to be much more typical going forward. The products listed under are noteworthy approvals in 2020 of an by now-authorized drug for use within an expanded population of sufferers: We think our estimate for this cate